Skip to main content
Signal8

Blank Andrew Scott

SEC insider (Form 3/4/5 filer). CIK 0001789894. Director at BioCardia, Inc. (BCDA). 7 reported Form 4/5 transactions since Sep 2024; latest on Jul 6, 2026. Located in SUNNYVALE, CA.

Companies Blank Andrew Scott has filed insider reports for

  • BioCardia, Inc. (BCDA): Director
Blank Andrew Scott profile photo

Blank Andrew Scott

CIK: 0001789894

Transaction Breakdown

Open Market Buys (P)3 (42.9%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BioCardia, Inc. logo
BCDA

BioCardia, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • BioCardia, Inc. logo
    BCDA

    BioCardia, Inc.

    Jul 6, 2026
    Award

    Stock Option (right to buy)

    Direct
    8K shares-
  • BioCardia, Inc. logo
    BCDA

    BioCardia, Inc.

    Dec 8, 2025
    Award

    Stock Option (right to buy)

    Direct
    12K shares-
  • BioCardia, Inc. logo
    BCDA

    BioCardia, Inc.

    Sep 19, 2025
    Purchase
    Indirect
    288K shares at avg. $1.25$360K
  • BioCardia, Inc. logo
    BCDA

    BioCardia, Inc.

    Jun 30, 2025
    Purchase
    Indirect
    72.3K shares at avg. $2.08$150K
  • BioCardia, Inc. logo
    BCDA

    BioCardia, Inc.

    Apr 23, 2025
    Purchase
    Indirect
    131.2K shares at avg. $1.91$250K
  • BioCardia, Inc. logo
    BCDA

    BioCardia, Inc.

    Oct 11, 2024
    Award

    Stock Option (right to buy)

    Direct
    829 shares-
  • BioCardia, Inc. logo
    BCDA

    BioCardia, Inc.

    Sep 3, 2024
    Award
    Indirect
    111K shares at avg. $3.00$333K

1-7 of 7